Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab

Saved in:
Bibliographic Details
Main Authors: Kommoss, S, Heitz, F, Winterhoff, B, Wang, C, Canzler, U, Aliferis, C, Belau, A, Wang, J, Hanker, L, Kommoss, F, du Bois, A, Ma, S, Sehouli, J, Kimmig, R, Tourani, R, Kurzeder, C, Mahner, S, Park-Simon, TW, Dowdy, SC, Pfisterer, J
Format: Conference Proceeding
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 10
container_start_page
container_title
container_volume 78
creator Kommoss, S
Heitz, F
Winterhoff, B
Wang, C
Canzler, U
Aliferis, C
Belau, A
Wang, J
Hanker, L
Kommoss, F
du Bois, A
Ma, S
Sehouli, J
Kimmig, R
Tourani, R
Kurzeder, C
Mahner, S
Park-Simon, TW
Dowdy, SC
Pfisterer, J
description
doi_str_mv 10.1055/s-0038-1671332
format conference_proceeding
fullrecord <record><control><sourceid>thieme</sourceid><recordid>TN_cdi_thieme_journals_10_1055_s_0038_1671332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1055_s_0038_1671332</sourcerecordid><originalsourceid>FETCH-thieme_journals_10_1055_s_0038_16713323</originalsourceid><addsrcrecordid>eNqVj81uwjAQhK2qSITClbNfwOBtfkjPFYg73C0n2sAix4nsxFL79F0kXqCn1ex8u6MRYgt6B7os91FpndcKqgPk-eebyKBgWde6eBeZ1lCp8lDCUqxifLAsvqDKxHChm6eOWusnOSQM1jkZ55AoWSepHwMve2STvGThqGNmooRMNdPPiHxlA1kv-UWLQY7sMh9lwBYpkb_JBpNt6XfubbMWi866iJvX_BDqdLx-n9V0J84xj2EOng0D2jxbmWiercyrVf5f_g8TiVcS</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab</title><source>PubMed Central</source><creator>Kommoss, S ; Heitz, F ; Winterhoff, B ; Wang, C ; Canzler, U ; Aliferis, C ; Belau, A ; Wang, J ; Hanker, L ; Kommoss, F ; du Bois, A ; Ma, S ; Sehouli, J ; Kimmig, R ; Tourani, R ; Kurzeder, C ; Mahner, S ; Park-Simon, TW ; Dowdy, SC ; Pfisterer, J</creator><creatorcontrib>Kommoss, S ; Heitz, F ; Winterhoff, B ; Wang, C ; Canzler, U ; Aliferis, C ; Belau, A ; Wang, J ; Hanker, L ; Kommoss, F ; du Bois, A ; Ma, S ; Sehouli, J ; Kimmig, R ; Tourani, R ; Kurzeder, C ; Mahner, S ; Park-Simon, TW ; Dowdy, SC ; Pfisterer, J</creatorcontrib><identifier>ISSN: 0016-5751</identifier><identifier>EISSN: 1438-8804</identifier><identifier>DOI: 10.1055/s-0038-1671332</identifier><language>eng</language><publisher>Stuttgart · New York: Georg Thieme Verlag KG</publisher><ispartof>Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (10)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,780,784,789,790,23930,23931,25140,27925</link.rule.ids></links><search><creatorcontrib>Kommoss, S</creatorcontrib><creatorcontrib>Heitz, F</creatorcontrib><creatorcontrib>Winterhoff, B</creatorcontrib><creatorcontrib>Wang, C</creatorcontrib><creatorcontrib>Canzler, U</creatorcontrib><creatorcontrib>Aliferis, C</creatorcontrib><creatorcontrib>Belau, A</creatorcontrib><creatorcontrib>Wang, J</creatorcontrib><creatorcontrib>Hanker, L</creatorcontrib><creatorcontrib>Kommoss, F</creatorcontrib><creatorcontrib>du Bois, A</creatorcontrib><creatorcontrib>Ma, S</creatorcontrib><creatorcontrib>Sehouli, J</creatorcontrib><creatorcontrib>Kimmig, R</creatorcontrib><creatorcontrib>Tourani, R</creatorcontrib><creatorcontrib>Kurzeder, C</creatorcontrib><creatorcontrib>Mahner, S</creatorcontrib><creatorcontrib>Park-Simon, TW</creatorcontrib><creatorcontrib>Dowdy, SC</creatorcontrib><creatorcontrib>Pfisterer, J</creatorcontrib><title>Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab</title><title>Geburtshilfe und Frauenheilkunde</title><addtitle>Geburtshilfe Frauenheilkd</addtitle><issn>0016-5751</issn><issn>1438-8804</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2018</creationdate><recordtype>conference_proceeding</recordtype><sourceid/><recordid>eNqVj81uwjAQhK2qSITClbNfwOBtfkjPFYg73C0n2sAix4nsxFL79F0kXqCn1ex8u6MRYgt6B7os91FpndcKqgPk-eebyKBgWde6eBeZ1lCp8lDCUqxifLAsvqDKxHChm6eOWusnOSQM1jkZ55AoWSepHwMve2STvGThqGNmooRMNdPPiHxlA1kv-UWLQY7sMh9lwBYpkb_JBpNt6XfubbMWi866iJvX_BDqdLx-n9V0J84xj2EOng0D2jxbmWiercyrVf5f_g8TiVcS</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Kommoss, S</creator><creator>Heitz, F</creator><creator>Winterhoff, B</creator><creator>Wang, C</creator><creator>Canzler, U</creator><creator>Aliferis, C</creator><creator>Belau, A</creator><creator>Wang, J</creator><creator>Hanker, L</creator><creator>Kommoss, F</creator><creator>du Bois, A</creator><creator>Ma, S</creator><creator>Sehouli, J</creator><creator>Kimmig, R</creator><creator>Tourani, R</creator><creator>Kurzeder, C</creator><creator>Mahner, S</creator><creator>Park-Simon, TW</creator><creator>Dowdy, SC</creator><creator>Pfisterer, J</creator><general>Georg Thieme Verlag KG</general><scope/></search><sort><creationdate>201810</creationdate><title>Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab</title><author>Kommoss, S ; Heitz, F ; Winterhoff, B ; Wang, C ; Canzler, U ; Aliferis, C ; Belau, A ; Wang, J ; Hanker, L ; Kommoss, F ; du Bois, A ; Ma, S ; Sehouli, J ; Kimmig, R ; Tourani, R ; Kurzeder, C ; Mahner, S ; Park-Simon, TW ; Dowdy, SC ; Pfisterer, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-thieme_journals_10_1055_s_0038_16713323</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kommoss, S</creatorcontrib><creatorcontrib>Heitz, F</creatorcontrib><creatorcontrib>Winterhoff, B</creatorcontrib><creatorcontrib>Wang, C</creatorcontrib><creatorcontrib>Canzler, U</creatorcontrib><creatorcontrib>Aliferis, C</creatorcontrib><creatorcontrib>Belau, A</creatorcontrib><creatorcontrib>Wang, J</creatorcontrib><creatorcontrib>Hanker, L</creatorcontrib><creatorcontrib>Kommoss, F</creatorcontrib><creatorcontrib>du Bois, A</creatorcontrib><creatorcontrib>Ma, S</creatorcontrib><creatorcontrib>Sehouli, J</creatorcontrib><creatorcontrib>Kimmig, R</creatorcontrib><creatorcontrib>Tourani, R</creatorcontrib><creatorcontrib>Kurzeder, C</creatorcontrib><creatorcontrib>Mahner, S</creatorcontrib><creatorcontrib>Park-Simon, TW</creatorcontrib><creatorcontrib>Dowdy, SC</creatorcontrib><creatorcontrib>Pfisterer, J</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kommoss, S</au><au>Heitz, F</au><au>Winterhoff, B</au><au>Wang, C</au><au>Canzler, U</au><au>Aliferis, C</au><au>Belau, A</au><au>Wang, J</au><au>Hanker, L</au><au>Kommoss, F</au><au>du Bois, A</au><au>Ma, S</au><au>Sehouli, J</au><au>Kimmig, R</au><au>Tourani, R</au><au>Kurzeder, C</au><au>Mahner, S</au><au>Park-Simon, TW</au><au>Dowdy, SC</au><au>Pfisterer, J</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab</atitle><btitle>Geburtshilfe und Frauenheilkunde</btitle><addtitle>Geburtshilfe Frauenheilkd</addtitle><date>2018-10</date><risdate>2018</risdate><volume>78</volume><issue>10</issue><issn>0016-5751</issn><eissn>1438-8804</eissn><cop>Stuttgart · New York</cop><pub>Georg Thieme Verlag KG</pub><doi>10.1055/s-0038-1671332</doi></addata></record>
fulltext fulltext
identifier ISSN: 0016-5751
ispartof Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (10)
issn 0016-5751
1438-8804
language eng
recordid cdi_thieme_journals_10_1055_s_0038_1671332
source PubMed Central
title Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A01%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-thieme&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Significant%20overall%20survival%20improvement%20in%20proliferative%20subtype%20ovarian%20cancer%20patients%20receiving%20bevacizumab&rft.btitle=Geburtshilfe%20und%20Frauenheilkunde&rft.au=Kommoss,%20S&rft.date=2018-10&rft.volume=78&rft.issue=10&rft.issn=0016-5751&rft.eissn=1438-8804&rft_id=info:doi/10.1055/s-0038-1671332&rft_dat=%3Cthieme%3E10_1055_s_0038_1671332%3C/thieme%3E%3Cgrp_id%3Ecdi_FETCH-thieme_journals_10_1055_s_0038_16713323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true